Safety Alert for Commercial Name: Videoduodenoscopes // Registration Number Anvisa: 10371280029 // Risk Class: II Medium Risk // Model Affected: ED-3490TK // Serial Number Affected: H110761, H110763 and H110765

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by Pentax Medical Brasil Materiais e Equipamentos Ltda; HOYA CORPORATION PENTAX MIYAGI FACTORY.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    1828
  • Date
    2016-03-09
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    The company that registers in Brazil notes: "It is recommended that all users of Pentax ED-3490TK videoduodenoscopes follow strictly the new instructions and procedures for high-level cleaning and disinfection included in the reprocessing and up-to-date operation manual. The updated reprocessing manual should be fully read by users and any questions or concerns should be immediately forwarded to Pentax Medical Brazil, its field technicians and / or regulatory affairs department, to ensure that all recommendations are clearly understood and in this way reduce the risk of contamination during ERCP / ERCP procedures. "
  • Reason
    In 2015 the fda issued a public safety notice informing of the potential association between duodenoscopes and incident reports on ercp cholangiopancreatography procedures associated with the presence of multiresistant bacteria in patients undergoing this procedure in a few institutions in the united states. since then pentax in conjunction with the fda, medical societies and healthcare professionals, has updated and validated reprocessing instructions for the ed-3490tk duodenoscope model.
  • Action
    After learning of these adverse events and the FDA safety communication, to inform health professionals about the potential association between duodenoscopes and incident reports during ERCP / ERCP in some hospitals in the United States, Pentax has been working with the FDA, as part of an industry initiative to determine what additional steps, if necessary, could be taken to reduce the risk of infection in flexible endoscopes used for ERCP / ERCP. Pentax has conducted tests to increase the safety margin associated with reprocessing of the ED-3490TK duodenoscope. In Brazil on 12/8/2015 Pentax Medical Brazil responded to Anvisa notification No.79 / 2015 / GEAAR / GGMON / ANVISA, indicating that upon completion of these tests it could provide a new reprocessing manual and instructions for all who purchased the duodenoscope Pentax model ED-3490TK. Field actions involve the following procedures: 1- Translate the new Pentax reprocessing and operation manual into Portuguese. 2- Communicate and send to all users of the ED-3490TK, the new reprocessing and operation manual, containing the new instructions for use, reprocessing, cleaning, disinfection and sterilization. 3- Perform reprocessing and cleaning training for all users who have purchased the ED-3490TK to ensure these instructions are understood.